The chemical substance with the name "(4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid" and CAS number "937395-08-9" is a complex organic compound characterized by its multi-functional structure. It features a piperazine moiety, which is known for its role in pharmacology, often contributing to the bioactivity of compounds. The presence of an ethoxycarbonyl group suggests potential for esterification reactions, while the quinoline derivative indicates possible interactions with biological targets, particularly in medicinal chemistry. The oxopentanoic acid component implies acidity and potential reactivity, making it a candidate for various chemical transformations. This compound may exhibit specific solubility characteristics based on its functional groups, influencing its behavior in biological systems. Overall, its intricate structure suggests potential applications in drug development, particularly in targeting specific biological pathways or mechanisms. Further studies would be necessary to elucidate its pharmacokinetic and pharmacodynamic properties.

(4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid

937395-08-9: The chemical substance with the name "(4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid" and CAS number "937395-08-9" is a complex organic compound characterized by its multi-functional structure. It features a piperazine moiety, which is known for its role in pharmacology, often contributing to the bioactivity of compounds. The presence of an ethoxycarbonyl group suggests potential for esterification reactions, while the quinoline derivative indicates possible interactions with biological targets, particularly in medicinal chemistry. The oxopentanoic acid component implies acidity and potential reactivity, making it a candidate for various chemical transformations. This compound may exhibit specific solubility characteristics based on its functional groups, influencing its behavior in biological systems. Overall, its intricate structure suggests potential applications in drug development, particularly in targeting specific biological pathways or mechanisms. Further studies would be necessary to elucidate its pharmacokinetic and pharmacodynamic properties.

<p>BX 667, a P2Y12 antagonist, inhibits ADP-induced platelet clumping in humans, dogs, rats with IC50s: 97, 317, 3000 nM.</p>

CAS 937395-08-9

(4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid

BX 667

Ref: TM-T26932